Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Protein-Protein Interaction

Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα

Meidan Ying, Qian Zhou, Xuejing Shao, Ji Cao, Hong Zhu, Bo Yang and Qiaojun He
Meidan Ying
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Zhou
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejing Shao
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji Cao
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Zhu
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Yang
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiaojun He
Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.TARG-15-B155 Published December 2015
  • Article
  • Info & Metrics
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2016 to December 2020

AbstractFull-text HTMLPDF
Total469014

Cited By

Article Information

Volume 14, Issue 12 Supplement 2, pp. B155

DOI 
https://doi.org/10.1158/1535-7163.TARG-15-B155

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514

Copyright & Usage 
©2015 American Association for Cancer Research.

Author Information

  1. Meidan Ying,
  2. Qian Zhou,
  3. Xuejing Shao,
  4. Ji Cao,
  5. Hong Zhu,
  6. Bo Yang, and
  7. Qiaojun He
  1. Zhejiang Univ. College of Pharmaceutical Sci., Hangzhou, China.
Previous
Back to top
Molecular Cancer Therapeutics: 14 (12 Supplement 2)
December 2015
Volume 14, Issue 12 Supplement 2
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Meidan Ying, Qian Zhou, Xuejing Shao, Ji Cao, Hong Zhu, Bo Yang and Qiaojun He
Mol Cancer Ther December 1 2015 (14) (12 Supplement 2) B155; DOI: 10.1158/1535-7163.TARG-15-B155

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Meidan Ying, Qian Zhou, Xuejing Shao, Ji Cao, Hong Zhu, Bo Yang and Qiaojun He
Mol Cancer Ther December 1 2015 (14) (12 Supplement 2) B155; DOI: 10.1158/1535-7163.TARG-15-B155
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Protein-Protein Interaction

  • Abstract LB-C02: In vitro on-target and selectivity profiling of small-molecule inhibitors of the Myc/Max heterodimeric complex
  • Abstract LB-B17: Characterization of small molecule inhibitors of the Nrf2-Keap1 interaction using MicroScale Thermophoresis
Show more Protein-Protein Interaction

Protein-Protein Interaction: Poster Presentations - Proffered Abstracts

  • Abstract LB-C02: In vitro on-target and selectivity profiling of small-molecule inhibitors of the Myc/Max heterodimeric complex
  • Abstract LB-B17: Characterization of small molecule inhibitors of the Nrf2-Keap1 interaction using MicroScale Thermophoresis
  • Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Show more Protein-Protein Interaction: Poster Presentations - Proffered Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement